DBVT Chart
See on advanced chart >
About
Dbv Technologies S.A. is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The company's therapeutic approach is based on epicutaneous immunotherapy,...
Read More
- HighlightA developer of therapeutics based on epicutaneous immunotherapy to treat severe food allergies
- ExchangeNASDAQ
- Listing Date10/22/2014
- Established Date03/29/2002
- Full-time Employees85
- Address177-181 avenue Pierre Brossolette 92120 Montrouge Paris France
- Tel33-1-55427878
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology
